Samuli Eldfors

12PUBLICATIONS

49CO-AUTHORS

Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Gene and molecular therapy

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (12)

Sort by Publication Date:

|May 25, 2026

Liquid Biopsy of HPV Cell-Free DNA Enables Blood-Based Early Detection and Molecular Stratification of HPV-Associated Cancer and Precancer Stages.

|Nov 24, 2025

Sensitivity to ATR-CHK1 pathway inhibition in AML/MDS is enhanced by <i>SRSF2</i> mutations and reduced by RUNX1 loss.

Samuli Eldfors, Sumit Rai, Vineet Sharma

|Jan 10, 2024

Monosomy 7/del(7q) cause sensitivity to inhibitors of nicotinamide phosphoribosyltransferase in acute myeloid leukemia.

Samuli Eldfors, Joseph Saad, Nemo Ikonen

|Dec 12, 2022

Erythroid/megakaryocytic differentiation confers BCL-XL dependency and venetoclax resistance in acute myeloid leukemia.

Heikki Kuusanmäki, Olli Dufva, Markus Vähä-Koskela

|Nov 18, 2021

Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia.

Disha Malani, Ashwini Kumar, Oscar Brück

|May 09, 2020

Somatic mTOR mutation in clonally expanded T lymphocytes associated with chronic graft versus host disease.

Daehong Kim, Giljun Park, Jani Huuhtanen

Pageof 2

Frequent Collaborators

O Kallioniemi

Satu Mustjoki

Kimmo Porkka

Caroline A Heckman

Mika Kontro

S Anders

Joseph Saad

Markus Vähä-Koskela

Tero Aittokallio

Jani Huuhtanen

Frequent Collaborators

O Kallioniemi

Satu Mustjoki

Kimmo Porkka

Caroline A Heckman